Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BNGO | BioNano Genomics, Inc. | 30.29% | 12.77 | 0.0% | $2627.57m | |
| MRNA | Moderna, Inc. | 10.15% | 144.32 | 0.0% | $2549.08m | |
| GILD | Gilead Sciences, Inc. | -0.43% | 66.65 | 1.0% | $646.90m | |
| AMGN | Amgen, Inc. | -0.47% | 252.30 | 1.3% | $561.92m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.75% | 547.21 | 2.7% | $486.47m | |
| CRSP | CRISPR Therapeutics AG | -1.25% | 186.14 | 0.6% | $481.91m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.73% | 160.90 | 2.0% | $474.03m | |
| NVAX | Novavax, Inc. | 2.14% | 129.70 | 92.9% | $426.38m | |
| ILMN | Illumina, Inc. | 1.20% | 411.14 | 3.5% | $401.50m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.95% | 239.85 | 1.9% | $365.29m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.72% | 96.55 | 13.8% | $358.52m | |
| BIIB | Biogen, Inc. | 1.41% | 273.23 | 1.7% | $326.42m | |
| BNTX | BioNTech SE | 1.39% | 109.95 | 0.0% | $302.49m | |
| EXAS | EXACT Sciences Corp. | 1.93% | 152.89 | 19.6% | $248.65m | |
| PACB | Pacific Biosciences of California, Inc. | -0.64% | 37.18 | 7.4% | $226.70m |
Company Profile
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Its products include Tavalisse, Fostamatinib and R835. The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.